Showing results (2261-2270 of 2,390) with videos related to
Sort By:
Pageof 239
Gastrointestinal Endoscopy|November 11, 2023
Aspirin exposure and its association with metal stent patency in malignant distal biliary obstruction: a large international multicenter propensity score-matched studyKristina Candido, Simon Bouchard, Christopher Hansen-Barkun, et al.Journal of Clinical Gastroenterology|September 18, 2025
Standardizing Success and Troubleshooting in EUS-Guided Gastroenterostomy: An International Technical Review (With Videos)Giuseppe Vanella, Francesco Frigo, Michiel Bronswijk, et al.Ejhaem|December 5, 2022
Selinexor-based regimens in patients with multiple myeloma after prior anti-B-cell maturation antigen treatmentMuhamed Baljevic, Cristina Gasparetto, Gary J Schiller, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 6, 2025
Phase III Trial of Pirtobrutinib Versus Idelalisib/Rituximab or Bendamustine/Rituximab in Covalent Bruton Tyrosine Kinase Inhibitor-Pretreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (BRUIN CLL-321)Jeff P Sharman, Talha Munir, Sebastian Grosicki, et al.European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|March 13, 2012
Genetic polymorphisms in the opioid receptor mu1 gene are associated with changes in libido and insomnia in methadone maintenance patientsSheng-Chang Wang, Hsiao-Hui Tsou, Chia-Hui Chen, et al.Medicine|September 22, 2018
Clinical features and outcomes of gastric neuroendocrine tumors after endoscopic diagnosis and treatment: A Digestive Endoscopy Society of Tawian (DEST)Chen-Shuan Chung, Cho-Lun Tsai, Yin-Yi Chu, et al.British Journal of Cancer|November 21, 2021
Once weekly selinexor, carfilzomib and dexamethasone in carfilzomib non-refractory multiple myeloma patientsCristina Gasparetto, Gary J Schiller, Sascha A Tuchman, et al.Therapeutic Advances in Gastroenterology|May 26, 2026
Optimal endoscopic drainage strategy for concomitant biliary and gastric outlet obstruction: a multicenter retrospective study (ENDO-GOBO)Thomas Beuchard, Jean-Philippe Ratone, Marion Schaefer, et al.NEJM Evidence|May 22, 2024
CAR T-Cell Immunotherapy in Minority Patients with LymphomaGuido Ghilardi, Staci Williamson, Raymone Pajarillo, et al.Bone Marrow Transplantation|October 6, 2015
Long-term survival outcomes of reduced-intensity allogeneic or autologous transplantation in relapsed grade 3 follicular lymphomaE Klyuchnikov, U Bacher, K Woo Ahn, et al.Pageof 239